Keyphrases
Schizophrenia Spectrum Disorders
100%
Antipsychotics
79%
Estrogen
64%
Pharmacotherapy
64%
Symptom Severity
57%
Pharmacological Treatment
50%
Evidence-based Recommendations
50%
Treatment of Women
50%
Testosterone
50%
Prolactin
50%
Divergent Effects
50%
Gonadal Hormones
50%
Prolactin Hormone
50%
Daily Functioning
50%
Speech Tracking
50%
Positive Symptoms
50%
Psychiatrists
50%
First-episode Psychosis
50%
Hyperprolactinemia
21%
Raloxifene
21%
Prolactin Levels
18%
Postmenopausal Women
14%
Meta-analysis
14%
Aripiprazole
14%
Adjusted Dose
14%
Female-specific
14%
Sex Differences
14%
Estrogen Level
12%
Processing Speed
12%
Verbal Fluency
12%
Symptom Score
12%
Working Memory
12%
Envelope Tracking
12%
Prescribed Dose
11%
Symptomatic Outcome
11%
Explained Variance
11%
Baseline Severity
11%
Hormonal Replacement Therapy
7%
Estrogen-like
7%
Improved Outcomes
7%
Older Women
7%
Symptomatology
7%
PubMed
7%
High Dose
7%
Therapeutic Drug Monitoring
7%
Tolerability
7%
Clinical Practice Guidelines
7%
Serum Concentration
7%
Contraceptives
7%
Embase
7%
Neuroscience
Schizophrenia Spectrum Disorder
100%
Antipsychotic
58%
Prolactin
50%
Sex Hormone
50%
Drug Therapy
50%
Auditory Cortex
50%
Superior Temporal Sulcus
50%
Gyri
37%
Raloxifene
30%
Temporoparietal Junction
25%
Functional Magnetic Resonance Imaging
25%
Typical Antipsychotic
24%
Meta-Analysis
20%
Aripiprazole
20%
Quetiapine
10%
Dementia Praecox
10%
Working Memory
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Pharmacotherapy
70%
Schizophrenia Spectrum Disorder
50%
Psychosis
50%
Positive Syndrome
50%
Raloxifene
30%
Hyperprolactinemia
30%
Randomized Controlled Trial
30%
Comorbidity
25%
Aripiprazole
20%
Typical Antipsychotic
20%
Symptom
20%
Contraceptive Agent
10%
Symptomatology
10%
Side Effect
10%
Tolerability
10%
Therapeutic Drug Monitoring
10%
Quetiapine
10%
